Chinese Journal of Integrative Medicine最新文献

筛选
英文 中文
Electroacupuncture Improves Pregnancy Outcomes of Assisted Reproduction and Mitochondrial Function of Granulosa Cells in Patients with Polycystic Ovary Syndrome of Phlegm-Dampness Syndrome. 电针对痰湿证多囊卵巢综合征辅助生殖妊娠结局及颗粒细胞线粒体功能的影响
IF 2.5 3区 医学
Chinese Journal of Integrative Medicine Pub Date : 2025-08-20 DOI: 10.1007/s11655-025-4216-z
Cong-Hui Pang, Dan-Yang Guo, Qi Wang, Ke-Hua Wang, Fang Lian
{"title":"Electroacupuncture Improves Pregnancy Outcomes of Assisted Reproduction and Mitochondrial Function of Granulosa Cells in Patients with Polycystic Ovary Syndrome of Phlegm-Dampness Syndrome.","authors":"Cong-Hui Pang, Dan-Yang Guo, Qi Wang, Ke-Hua Wang, Fang Lian","doi":"10.1007/s11655-025-4216-z","DOIUrl":"https://doi.org/10.1007/s11655-025-4216-z","url":null,"abstract":"<p><strong>Objective: </strong>To explore the effects of electroacupuncture (EA) on pregnancy outcomes after assisted reproduction and mitochondrial function of granulosa cells (GCs) in patients with polycystic ovary syndrome (PCOS) and phlegm-dampness syndrome.</p><p><strong>Methods: </strong>In this randomized controlled trial, 90 infertile women with PCOS and phlegm-dampness syndrome were recruited between August 2022 and December 2022. Patients were randomly assigned to the EA and control groups using a random sequence of codes in the order of enrolment, with 45 in in each group. Both groups underwent the ovarian stimulation protocol. The patients in the EA group received EA therapy including Zhongwan (CV 12), Qihai (CV 6), bilateral Xuehai (SP 10), Sanyinjiao (SP 6), Yinlingquan (SP 9), Tianshu (ST 25), Zusanli (ST 36), and Fenglong (ST 40), and the patients in the control group was treated with pseudo-acupuncture. The intervention was 25 min twice a week for a total of 6 times until the trigger day after menstruation had ended in the cycle before oocyte retrieval. The primary outcomes were clinical pregnancy rate (CPR) and the number of high-quality embryos. The secondary outcomes were (1) pregnancy-related indicators, including fresh embryo transfer rate (ETR), ovarian hyperstimulation syndrome (OHSS) rate, early pregnancy loss rate (ePLR), ectopic pregnancy rate, live birth rate (LBR), and cumulative CPR; (2) mitochondrial autophagy and mitochondrial membrane potential (MMP) in GCs; and (3) scoring for Chinese medicine syndrome. Adverse events to assess clinical safety were also monitored.</p><p><strong>Results: </strong>The cumulative CPR was significantly higher in the EA group (42/45, 93.3%) than in the control group (38/45, 84.4%, P=0.036). The number of high-quality embryos and fresh ETR in the EA group were higher than those in the control group (3.80±1.65 vs. 2.44±1.34, P<0.001; 46.7% vs 24.4%, P=0.028). Ectopic pregnancies were not observed in either group. There were no significant differences in the fresh CPR, OHSS rate, ePLR or LBR between the two groups (P>0.05). Compared with the control group, the EA group showed lower expression levels of miR-146a-5p mRNA and P62 protein in GCs and higher levels of MMP and the LC3-II/LC3-I protein ratio (all P<0.01). The phlegm-dampness syndrome scores of the EA group were significantly lower than those of the control group (P<0.01).</p><p><strong>Conclusions: </strong>EA significantly improved pregnancy outcomes in patients with PCOS and phlegm dampness syndrome. Mechanistically, this effect may be related to EA in decreasing miR-146a-5p mRNA expression, promoting mitochondrial autophagy in GCs, and improving mitochondrial function, which may contribute to improved oocyte quality. (Trial registration No. ChiCTR2200062915).</p>","PeriodicalId":10005,"journal":{"name":"Chinese Journal of Integrative Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144944842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advantages of Chinese Medicines for Diabetic Retinopathy and Mechanisms: Focused on Inflammation and Oxidative Stress. 中药治疗糖尿病视网膜病变的优势及机制:以炎症和氧化应激为主。
IF 2.5 3区 医学
Chinese Journal of Integrative Medicine Pub Date : 2025-08-15 DOI: 10.1007/s11655-025-3938-2
Li-Shuo Dong, Chong-Xiang Xue, Jia-Qi Gao, Yue Hu, Ze-Zheng Kang, A-Ru Sun, Jia-Rui Li, Xiao-Lin Tong, Xiu-Ge Wang, Xiu-Yang Li
{"title":"Advantages of Chinese Medicines for Diabetic Retinopathy and Mechanisms: Focused on Inflammation and Oxidative Stress.","authors":"Li-Shuo Dong, Chong-Xiang Xue, Jia-Qi Gao, Yue Hu, Ze-Zheng Kang, A-Ru Sun, Jia-Rui Li, Xiao-Lin Tong, Xiu-Ge Wang, Xiu-Yang Li","doi":"10.1007/s11655-025-3938-2","DOIUrl":"https://doi.org/10.1007/s11655-025-3938-2","url":null,"abstract":"","PeriodicalId":10005,"journal":{"name":"Chinese Journal of Integrative Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144854739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-tumor Effects of Pollen Pini on Hepatocarcinoma SMMC-7721 Cells via Modulation of PI3K-Akt Signaling Pathway. 花粉Pini通过调节PI3K-Akt信号通路对肝癌SMMC-7721细胞的抗肿瘤作用
IF 2.5 3区 医学
Chinese Journal of Integrative Medicine Pub Date : 2025-08-15 DOI: 10.1007/s11655-025-4132-2
Yuan-Hong Chen, Wei-Xin Xu, Wen-Jun Yu, Chun-Fang Wang, Chun Guo, Yan-Hong Luo
{"title":"Anti-tumor Effects of Pollen Pini on Hepatocarcinoma SMMC-7721 Cells via Modulation of PI3K-Akt Signaling Pathway.","authors":"Yuan-Hong Chen, Wei-Xin Xu, Wen-Jun Yu, Chun-Fang Wang, Chun Guo, Yan-Hong Luo","doi":"10.1007/s11655-025-4132-2","DOIUrl":"https://doi.org/10.1007/s11655-025-4132-2","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the effect of Pollen Pini (PP) on SMMC-7721 hepatoma cells.</p><p><strong>Methods: </strong>The anti-proliferative effects of PP on SMMC-7721 cells were evaluated using cell counting kit-8 assay following 48 h treatment with concentrations ranging from 1.25 to 37.50 µg/µL Flow cytometry analysis at the half maximal inhibitory concentration (IC<sub>50</sub>) revealed significant apoptosis induction and cell cycle alterations. For in vivo evaluation, SMMC-7721 xenograft-bearing nude mice were administered either vehicle (0.9% NaCl) or PP (500 mg/kg) via intraperitoneal injection every other day for 3 weeks. Subsequent tumor analysis included mass spectrometry-based proteomics and examination of phosphoinositide-3 kinase (PI3K)/protein kinase B (Akt)/Myc pathway proteins by immunohistochemistry and Western blot. Combination therapy with 25 µmol/L PI3K inhibitor and PP (IC<sub>50</sub>) showed optimal efficacy, with Western blot revealing maximal protein modulation at 24 h.</p><p><strong>Results: </strong>PP had an anti-tumor effect on SMMC-7721 cells in vitro, with the IC<sub>50</sub> concentration of 18.94 mg/mL. PP could promote the death of SMMC-7721 cells (P<0.01) and regulate the cell cycle more in G<sub>0</sub>/G<sub>1</sub> phase cells (P<0.01). After the treatment effect of PP, the protein content of SMMC-7721 cells changed and the contents of cancer-promoting proteins PI3K, Akt and Myc decreased (P<0.01). PI3K inhibitor could reduce the proliferation of SMMC-7721 cells, and PI3K inhibitor combined with PP significantly reduced the expression of PI3K in SMMC-7721 cells (P<0.01).</p><p><strong>Conclusion: </strong>PP has an anti-tumor effect on SMMC-7721 cells through the PI3K-Akt signaling pathway.</p>","PeriodicalId":10005,"journal":{"name":"Chinese Journal of Integrative Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144854740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Syzygium aromaticum L. (Clove): A Comprehensive Reveiw of Its Ethnopharmacological Uses and Pharmacological Activities. 丁香:民族药理学用途和药理活性的综合综述。
IF 2.5 3区 医学
Chinese Journal of Integrative Medicine Pub Date : 2025-08-15 DOI: 10.1007/s11655-025-4141-1
Tae-Young Gil, Sung-Jin Kim, Hyo-Jin An
{"title":"Syzygium aromaticum L. (Clove): A Comprehensive Reveiw of Its Ethnopharmacological Uses and Pharmacological Activities.","authors":"Tae-Young Gil, Sung-Jin Kim, Hyo-Jin An","doi":"10.1007/s11655-025-4141-1","DOIUrl":"https://doi.org/10.1007/s11655-025-4141-1","url":null,"abstract":"","PeriodicalId":10005,"journal":{"name":"Chinese Journal of Integrative Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144854741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Natural Products to Target Ferroptosis in Urologic Malignancies: Advancements from Molecular Mechanisms to Therapeutic Strategies. 探索针对泌尿系统恶性肿瘤铁下垂的天然产物:从分子机制到治疗策略的进展。
IF 2.5 3区 医学
Chinese Journal of Integrative Medicine Pub Date : 2025-08-13 DOI: 10.1007/s11655-025-4140-2
Tian-Yi Tao, Hua Gong, Bo Yang
{"title":"Exploring Natural Products to Target Ferroptosis in Urologic Malignancies: Advancements from Molecular Mechanisms to Therapeutic Strategies.","authors":"Tian-Yi Tao, Hua Gong, Bo Yang","doi":"10.1007/s11655-025-4140-2","DOIUrl":"https://doi.org/10.1007/s11655-025-4140-2","url":null,"abstract":"","PeriodicalId":10005,"journal":{"name":"Chinese Journal of Integrative Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chinese Medicine Strategies for Influenza A: Research Progress and Prospects. 甲型流感的中医药策略:研究进展与展望。
IF 2.5 3区 医学
Chinese Journal of Integrative Medicine Pub Date : 2025-08-11 DOI: 10.1007/s11655-025-3941-7
Zi-Wei Guo, Jiu-Chong Wang, Dong-Jie Wu, Wen-Liang Lyu
{"title":"Chinese Medicine Strategies for Influenza A: Research Progress and Prospects.","authors":"Zi-Wei Guo, Jiu-Chong Wang, Dong-Jie Wu, Wen-Liang Lyu","doi":"10.1007/s11655-025-3941-7","DOIUrl":"https://doi.org/10.1007/s11655-025-3941-7","url":null,"abstract":"","PeriodicalId":10005,"journal":{"name":"Chinese Journal of Integrative Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Curcumin Ameliorates Cisplatin-Induced Cardiovascular Injuries by Upregulating ERK/p-ERK Expression in Rats. 姜黄素通过上调ERK/p-ERK表达改善大鼠顺铂诱导的心血管损伤
IF 2.5 3区 医学
Chinese Journal of Integrative Medicine Pub Date : 2025-08-01 Epub Date: 2025-06-13 DOI: 10.1007/s11655-025-4017-4
Jun-Tao Hao, Meng-Piao Lin, Jin Wang, Feng Song, Xiao-Jie Bai
{"title":"Curcumin Ameliorates Cisplatin-Induced Cardiovascular Injuries by Upregulating ERK/p-ERK Expression in Rats.","authors":"Jun-Tao Hao, Meng-Piao Lin, Jin Wang, Feng Song, Xiao-Jie Bai","doi":"10.1007/s11655-025-4017-4","DOIUrl":"10.1007/s11655-025-4017-4","url":null,"abstract":"<p><strong>Objective: </strong>To investigate cisplatin-induced cardiovascular toxicity and explore the protective effects and potential mechanism of curcumin co-treatment.</p><p><strong>Methods: </strong>Forty adult male Sprague-Dawley rats were numbered and randomly divided into control group, cisplatin group (7.5 mg/kg, once a week, for 2 weeks), curcumin group (200 mg/kg per day, for 2 weeks) and cisplatin+curcumin group (cisplatin 7.5 mg/kg, once a week, and curcumin 200 mg/kg per day for 2 weeks) by a random number table method, with 10 rats in each group. Cardiac and vascular morphology and functions were assessed using hematoxylin-eosin and Masson's trichrome staining, serum indexes detection, echocardiography, electrocardiogram (ECG), blood pressure monitoring, vascular ring isometric tension measurement, and left ventricular pressure evaluation. The expressions of extracellular signal-regulated kinases (ERK) and phosphorylated-ERK (p-ERK) were analyzed by immunohistochemical staining.</p><p><strong>Results: </strong>Cisplatin treatment induced notable cardiac alteration, as evidenced by changes in cardiac morphology, elevated serum enzymes (P<0.05), ECG abnormalities, and increased left ventricular end-diastolic pressure (P<0.05). Meanwhile, cisplatin significantly increased arterial pulse pressure (P<0.01), primarily due to a decrease in diastolic blood pressure. Severe fibrosis was also observed in the thoracic aorta wall. In vascular ring experiments, cisplatin treatment led to a significant reduction in phenylephrine-induced contraction (P<0.05) and acetylcholine-induced relaxation (P<0.01). Notably, Curcumin co-administration significantly alleviated cisplatin-induced cardiovascular damages, as demonstrated by improvement in these parameters. Furthermore, ERK expression in the myocardium and p-ERK expression in vascular smooth muscle cells were significantly upregulated following curcumin co-treatment.</p><p><strong>Conclusions: </strong>Curcumin protects the heart and vasculature from cisplatin-induced damages, likely by upregulating ERK/p-ERK expression. These findings suggest that curcumin may serve as a promising therapeutic strategy for mitigating cisplatin-associated cardiovascular toxicity during tumor chemotherapy. In vitro cell culture experiments are needed to clarify the underlying mechanism.</p>","PeriodicalId":10005,"journal":{"name":"Chinese Journal of Integrative Medicine","volume":" ","pages":"717-725"},"PeriodicalIF":2.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shexiang Tongxin Dropping Pill Improves Stable Angina Patients with Phlegm-Heat and Blood-Stasis Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. 麝香通心滴丸改善痰热血瘀证稳定期心绞痛患者疗效:一项多中心、随机、双盲、安慰剂对照试验
IF 2.5 3区 医学
Chinese Journal of Integrative Medicine Pub Date : 2025-08-01 Epub Date: 2025-06-13 DOI: 10.1007/s11655-025-4014-7
Ying-Qiang Zhao, Yong-Fa Xing, Ke-Yong Zou, Wei-Dong Jiang, Ting-Hai Du, Bo Chen, Bao-Ping Yang, Bai-Ming Qu, Li-Yue Wang, Gui-Hong Gong, Yan-Ling Sun, Li-Qi Wang, Gao-Feng Zhou, Yu-Gang Dong, Min Chen, Xue-Juan Zhang, Tian-Lun Yang, Min-Zhou Zhang, Ming-Jun Zhao, Yue Deng, Chang-Jiang Xiao, Lin Wang, Bao-He Wang
{"title":"Shexiang Tongxin Dropping Pill Improves Stable Angina Patients with Phlegm-Heat and Blood-Stasis Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.","authors":"Ying-Qiang Zhao, Yong-Fa Xing, Ke-Yong Zou, Wei-Dong Jiang, Ting-Hai Du, Bo Chen, Bao-Ping Yang, Bai-Ming Qu, Li-Yue Wang, Gui-Hong Gong, Yan-Ling Sun, Li-Qi Wang, Gao-Feng Zhou, Yu-Gang Dong, Min Chen, Xue-Juan Zhang, Tian-Lun Yang, Min-Zhou Zhang, Ming-Jun Zhao, Yue Deng, Chang-Jiang Xiao, Lin Wang, Bao-He Wang","doi":"10.1007/s11655-025-4014-7","DOIUrl":"10.1007/s11655-025-4014-7","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the efficacy and safety of Shexiang Tongxin Dropping Pill (STDP) in treating stable angina patients with phlegm-heat and blood-stasis syndrome by exercise duration and metabolic equivalents.</p><p><strong>Methods: </strong>This multicenter, randomized, double-blind, placebo-controlled clinical trial enrolled stable angina patients with phlegm-heat and blood-stasis syndrome from 22 hospitals. They were randomized 1:1 to STDP (35 mg/pill, 6 pills per day) or placebo for 56 days. The primary outcome was the exercise duration and metabolic equivalents (METs) assessed by the standard Bruce exercise treadmill test after 56 days of treatment. The secondary outcomes included the total angina symptom score, Chinese medicine (CM) symptom scores, Seattle Angina Questionnaire (SAQ) scores, changes in ST-T on electrocardiogram and adverse events (AEs).</p><p><strong>Results: </strong>This trial enrolled 309 patients, including 155 and 154 in the STDP and placebo groups, respectively. STDP significantly prolonged exercise duration with an increase of 51.0 s, compared to a decrease of 12.0 s with placebo (change rate: -11.1% vs. 3.2%, P<0.01). The increase in METs was significantly greater in the STDP group than in the placebo group (change: -0.4 vs. 0.0, change rate: -5.0% vs. 0.0%, P<0.01). The improvement of total angina symptom scores (25.0% vs. 0.0%), CM symptom scores (38.7% vs. 11.8%), reduction of nitroglycerin consumption (100.0% vs. 11.3%), and all domains of SAQ, were significantly greater with STDP than placebo (all P<0.01). The changes in Q-T intervals at 28 and 56 days from baseline were similar between the two groups (both P>0.05). Twenty-five participants (16.3%) with STDP and 16 (10.5%) with placebo experienced AEs (P=0.131), with no serious AEs observed.</p><p><strong>Conclusion: </strong>STDP could improve exercise tolerance in patients with stable angina and phlegm-heat and blood stasis syndrome, with a favorable safety profile. (Registration No. ChiCTR-IPR-15006020).</p>","PeriodicalId":10005,"journal":{"name":"Chinese Journal of Integrative Medicine","volume":" ","pages":"685-693"},"PeriodicalIF":2.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural Anti-aging Herb: Role and Potential of Astragalus membranaceus. 天然抗衰老中药:黄芪的作用与潜力。
IF 2.5 3区 医学
Chinese Journal of Integrative Medicine Pub Date : 2025-08-01 Epub Date: 2025-05-14 DOI: 10.1007/s11655-025-4009-4
Shu-Dong Ma, Rong Yuan, Mei-Wen Huang, Qi-Qi Xin, Yu Miao, Yi-Zhun Zhu, Ke-Ji Chen, Wei-Hong Cong
{"title":"Natural Anti-aging Herb: Role and Potential of Astragalus membranaceus.","authors":"Shu-Dong Ma, Rong Yuan, Mei-Wen Huang, Qi-Qi Xin, Yu Miao, Yi-Zhun Zhu, Ke-Ji Chen, Wei-Hong Cong","doi":"10.1007/s11655-025-4009-4","DOIUrl":"10.1007/s11655-025-4009-4","url":null,"abstract":"","PeriodicalId":10005,"journal":{"name":"Chinese Journal of Integrative Medicine","volume":" ","pages":"743-751"},"PeriodicalIF":2.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143975810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plastrum Testudinis Stimulates Bone Formation through Wnt/β-catenin Signaling Pathway Regulated by miR-214. 鼠板通过miR-214调控的Wnt/β-catenin信号通路刺激骨形成。
IF 2.5 3区 医学
Chinese Journal of Integrative Medicine Pub Date : 2025-08-01 Epub Date: 2025-05-13 DOI: 10.1007/s11655-025-4012-9
Qing Lin, Bi-Yi Zhao, Xiao-Yun Li, Wei-Peng Sun, Hong-Hao Huang, Yu-Mei Yang, Hao-Yu Wang, Xiao-Feng Zhu, Li Yang, Rong-Hua Zhang
{"title":"Plastrum Testudinis Stimulates Bone Formation through Wnt/β-catenin Signaling Pathway Regulated by miR-214.","authors":"Qing Lin, Bi-Yi Zhao, Xiao-Yun Li, Wei-Peng Sun, Hong-Hao Huang, Yu-Mei Yang, Hao-Yu Wang, Xiao-Feng Zhu, Li Yang, Rong-Hua Zhang","doi":"10.1007/s11655-025-4012-9","DOIUrl":"10.1007/s11655-025-4012-9","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the Wnt signaling pathway and miRNAs mechanism of extracts of Plastrum Testudinis (PT) in the treatment of osteoporosis (OP).</p><p><strong>Methods: </strong>Thirty female Sprague Dawley rats were randomly divided into 5 groups by random number table method, including sham group, ovariectomized group (OVX), ovariectomized groups treated with high-, medium-, and low-dose PT (160, 80, 40 mg/kg per day, respectively), with 6 rats in each group. Except for the sham group, the other rats underwent bilateral ovariectomy to simulate OP and received PT by oral gavage for 10 consecutive weeks. After treatment, bone mineral density was measured by dual-energy X-ray absorptiometry; bone microstructure was analyzed by micro-computed tomography and hematoxylin and eosin staining; and the expressions of osteogenic differentiation-related factors were detected by immunochemistry, Western blot, and quantitative polymerase chain reaction. In addition, Dickkopf-1 (Dkk-1) was used to inhibit the Wnt signaling pathway in bone marrow mesenchymal stem cells (BMSCs) and miRNA overexpression was used to evaluate the effect of miR-214 on the osteogenic differentiation of BMSCs. Subsequently, PT extract was used to rescue the effects of Dkk-1 and miR-214, and its impacts on the osteogenic differentiation-related factors of BMSCs were evaluated.</p><p><strong>Results: </strong>PT-M and PT-L significantly reduced the weight gain in OVX rats (P<0.05). PT also regulated the bone mass and bone microarchitecture of the femur in OVX rats, and increased the expressions of bone formation-related factors including alkaline phosphatase, bone morphogenetic protein type 2, collagen type I alpha 1, and runt-related transcription factor 2 when compared with the OVX group (P<0.05 or P<0.01). Meanwhile, different doses of PT significantly rescued the inhibition of Wnt signaling pathway-related factors in OVX rats, and increased the mRNA or protein expressions of Wnt3a, β-catenin, glycogen synthase kinase-3β, and low-density lipoprotein receptor-related protein 5 (P<0.05 or P<0.01). PT stimulated the osteogenic differentiation of BMSCs inhibited by Dkk-1 and activated the Wnt signaling pathway. In addition, the expression of miR-214 was decreased in OVX rats (P<0.01), and it was negatively correlated with the osteogenic differentiation of BMSCs (P<0.01). MiR-214 mimic inhibited Wnt signaling pathway in BMSCs (P<0.05 or P<0.01). Conversely, PT effectively counteracted the effect of miR-214 mimic, thereby activating the Wnt signaling pathway and stimulating osteogenic differentiation in BMSCs (P<0.05 or P<0.01).</p><p><strong>Conclusion: </strong>PT stimulates bone formation in OVX rats through β-catenin-mediated Wnt signaling pathway, which may be related to inhibiting miR-214 in BMSCs.</p>","PeriodicalId":10005,"journal":{"name":"Chinese Journal of Integrative Medicine","volume":" ","pages":"707-716"},"PeriodicalIF":2.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143955933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信